These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24769434)

  • 21. Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder.
    Mota-Pereira J; Silverio J; Carvalho S; Ribeiro JC; Fonte D; Ramos J
    J Psychiatr Res; 2011 Aug; 45(8):1005-11. PubMed ID: 21377690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increases in orbitofrontal cortex thickness following antidepressant treatment are associated with changes in resting state autonomic function in adolescents with major depression - Preliminary findings from a pilot study.
    Koenig J; Westlund Schreiner M; Klimes-Dougan B; Ubani B; Mueller BA; Lim KO; Kaess M; Cullen KR
    Psychiatry Res Neuroimaging; 2018 Nov; 281():35-42. PubMed ID: 30216863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
    Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
    Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in heart rate variability during TOVA testing in patients with major depressive disorder.
    Shen TW; Liu FC; Chen SJ; Chen ST
    Psychiatry Clin Neurosci; 2013 Jan; 67(1):35-40. PubMed ID: 23331286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of heart rate in treatment of major depression with ketamine in two controlled trials.
    Meyer T; Brunovsky M; Horacek J; Novak T; Andrashko V; Seifritz E; Olbrich S
    Clin Neurophysiol; 2021 Jun; 132(6):1339-1346. PubMed ID: 33888426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of Heart Rate Variability and Heart Rate Turbulence in Patients with Depressive Illness Treated with Selective Serotonin Reuptake Inhibitors.
    Giurgi-Oncu C; Tudoran C; Enatescu VR; Tudoran M; Pop GN; Bredicean C
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33167574
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between symptoms of depression and heart rate variability: An exploratory study.
    Borrione L; Brunoni AR; Sampaio-Junior B; Aparicio LM; Kemp AH; Benseñor I; Lotufo PA; Fraguas R
    Psychiatry Res; 2018 Apr; 262():482-487. PubMed ID: 28958456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
    Signorovitch J; Ramakrishnan K; Ben-Hamadi R; Yu AP; Wu EQ; Dworak H; Erder MH
    Curr Med Res Opin; 2011 Jun; 27(6):1089-96. PubMed ID: 21438794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
    Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA).
    Licht CM; de Geus EJ; Zitman FG; Hoogendijk WJ; van Dyck R; Penninx BW
    Arch Gen Psychiatry; 2008 Dec; 65(12):1358-67. PubMed ID: 19047522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heart and brain -- the influence of psychiatric disorders and their therapy on the heart rate variability].
    Birkhofer A; Schmidt G; Förstl H
    Fortschr Neurol Psychiatr; 2005 Apr; 73(4):192-205. PubMed ID: 15806437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrative assessment of the psychophysiologic alterations in young women with recurrent major depressive disorder.
    Chang JS; Yoo CS; Yi SH; Her JY; Choi HM; Ha TH; Park T; Ha K
    Psychosom Med; 2012 Jun; 74(5):495-500. PubMed ID: 22408133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart and soul: heart rate variability and major depression.
    Kidwell M; Ellenbroek BA
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):152-164. PubMed ID: 29543649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.